RANI THERAPEUTICS HOLDINGS, INC.: total assets
Total assets for RANI THERAPEUTICS HOLDINGS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All RANI THERAPEUTICS HOLDINGS, INC. financial histories
What this measure means
Resources recognized on the balance sheet. Book assets are not the market value of the business.
Exact concept: us-gaap:Assets. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 58,621,000 | USD | 2026-03-26 | 10-K · 0001193125-26-126417 |
| At date | 2024-12-31 | 36,634,000 | USD | 2026-03-26 | 10-K · 0001193125-26-126417 |
| At date | 2023-12-31 | 57,916,000 | USD | 2025-03-31 | 10-K · 0000950170-25-047740 |
| At date | 2022-12-31 | 108,027,000 | USD | 2024-03-20 | 10-K · 0000950170-24-034163 |
| At date | 2021-12-31 | 124,207,000 | USD | 2023-03-22 | 10-K · 0000950170-23-009178 |
| At date | 2020-12-31 | 79,415,000 | USD | 2022-03-31 | 10-K · 0000950170-22-005088 |
Related financial histories
- RANI THERAPEUTICS HOLDINGS, INC.: total liabilities
- RANI THERAPEUTICS HOLDINGS, INC.: stockholders equity
- RANI THERAPEUTICS HOLDINGS, INC.: cash and cash equivalents
- RANI THERAPEUTICS HOLDINGS, INC.: net income or loss
- RANI THERAPEUTICS HOLDINGS, INC.: operating cash flow
- RANI THERAPEUTICS HOLDINGS, INC.: capital expenditure payments
- RANI THERAPEUTICS HOLDINGS, INC.: contract revenue excluding tax
- RANI THERAPEUTICS HOLDINGS, INC.: financing cash flow
- RANI THERAPEUTICS HOLDINGS, INC.: investing cash flow
- RANI THERAPEUTICS HOLDINGS, INC.: retained earnings or deficit
- RANI THERAPEUTICS HOLDINGS, INC.: basic weighted-average shares
- RANI THERAPEUTICS HOLDINGS, INC.: diluted weighted-average shares
- RANI THERAPEUTICS HOLDINGS, INC.: basic earnings per share
- RANI THERAPEUTICS HOLDINGS, INC.: diluted earnings per share
- RANI THERAPEUTICS HOLDINGS, INC.: income tax expense or benefit
- RANI THERAPEUTICS HOLDINGS, INC.: net property, plant and equipment
- RANI THERAPEUTICS HOLDINGS, INC.: share-based compensation expense
- RANI THERAPEUTICS HOLDINGS, INC.: operating income or loss
- RANI THERAPEUTICS HOLDINGS, INC.: current assets
- RANI THERAPEUTICS HOLDINGS, INC.: interest expense
- RANI THERAPEUTICS HOLDINGS, INC.: current liabilities
- RANI THERAPEUTICS HOLDINGS, INC.: current accounts payable
- RANI THERAPEUTICS HOLDINGS, INC.: net current accounts receivable
- RANI THERAPEUTICS HOLDINGS, INC.: operating expenses
- RANI THERAPEUTICS HOLDINGS, INC.: research and development expense
Inspect the source
- Entity
- RANI THERAPEUTICS HOLDINGS, INC. / CIK 0001856725
- Captured
- 2026-09-21T17:33:03.712Z
- SEC response SHA-256
80580b79921e582d61d3d94fcb8ea889bc850b1294e12598072aa1a5e863bff3
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001856725.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))